Home
SDGR
SDGR News

Latest Schrodinger Inc. (SDGR) News on March 31, 2025

Schrödinger (NASDAQ:SDGR) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

4 days ago

Schrödinger (NASDAQ:SDGR) Is In A Good Position To Deliver On Growth Plans

Argus Research

5 days ago

SDGR: Lowering target price to $23.00

Schrödinger to Present Preclinical Data at AACR Annual Meeting

Business Wire

6 days ago

Schrödinger to Present Preclinical Data at AACR Annual Meeting

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

13 days ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen

Business Wire

21 days ago

Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen

Argus Research

a month ago

SDGR: What does Argus have to say about SDGR?

Schrödinger Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a month ago

Schrödinger Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Thomson Reuters StreetEvents

a month ago

Q4 2024 Schrodinger Inc Earnings Call

Schrodinger Inc (SDGR) Q4 2024 Earnings Call Highlights: Strong Software Growth Amidst Revenue ...

GuruFocus.com

a month ago

Schrodinger Inc (SDGR) Q4 2024 Earnings Call Highlights: Strong Software Growth Amidst Revenue ...

Schrodinger, Inc. (SDGR) Reports Q4 Loss, Tops Revenue Estimates

Zacks

a month ago

Schrodinger, Inc. (SDGR) Reports Q4 Loss, Tops Revenue Estimates

Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results

Business Wire

a month ago

Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results

Argus Research

a month ago

SDGR: Lowering target price to $17.00

Schrodinger Inc (SDGR) Q4 2024: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

a month ago

Schrodinger Inc (SDGR) Q4 2024: Everything You Need To Know Ahead Of Earnings

Schrödinger to Participate in Upcoming Investor Conferences

Business Wire

a month ago

Schrödinger to Participate in Upcoming Investor Conferences

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a month ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Argus Research

a month ago

SDGR: Raising target price to $21.00

Why Xpeng (XPEV) and Schrodinger (SDGR) Are Advancing Today

Insider Monkey

a month ago

Why Xpeng (XPEV) and Schrodinger (SDGR) Are Advancing Today

Schrodinger Stock Scores IBD Rating Upgrade

Investor's Business Daily

a month ago

Schrodinger Stock Scores IBD Rating Upgrade

Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26

Business Wire

2 months ago

Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26

Argus Research

2 months ago

SDGR: What does Argus have to say about SDGR?

Strong week for Schrödinger (NASDAQ:SDGR) shareholders doesn't alleviate pain of five-year loss

Simply Wall St.

2 months ago

Strong week for Schrödinger (NASDAQ:SDGR) shareholders doesn't alleviate pain of five-year loss

Schrödinger (SDGR): Revolutionizing Biopharma with Quantum Mechanics and AI

Insider Monkey

2 months ago

Schrödinger (SDGR): Revolutionizing Biopharma with Quantum Mechanics and AI

Argus Research

2 months ago

SDGR: Raising target price to $20.00

Schrödinger, Inc. (SDGR): Quantum Mechanics Meets AI in Biopharma, Backed by Hunterbrook’s ‘Key AI Winner’ Endorsement

Insider Monkey

2 months ago

Schrödinger, Inc. (SDGR): Quantum Mechanics Meets AI in Biopharma, Backed by Hunterbrook’s ‘Key AI Winner’ Endorsement

Why Schrödinger, Inc. (SDGR) Is Skyrocketing Now

Insider Monkey

2 months ago

Why Schrödinger, Inc. (SDGR) Is Skyrocketing Now

Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last?

Zacks

2 months ago

Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last?

Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping

Insider Monkey

2 months ago

Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

2 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Argus Research

2 months ago

SDGR: Raising target price to $17.00

Argus Research

3 months ago

SDGR: Lowering target price to $15.00

Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities

Business Wire

3 months ago

Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities

Argus Research

3 months ago

SDGR: Lowering target price to $16.00

Argus Research

3 months ago

SDGR: Lowering target price to $17.00

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

3 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Argus Research

4 months ago

SDGR: What does Argus have to say about SDGR?

Argus Research

4 months ago

SDGR: Raising target price to $18.00

Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference

Business Wire

4 months ago

Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

4 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative

Business Wire

4 months ago

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative

Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

5 months ago

Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Schrodinger announces expanded license agreement with Novartis

TipRanks

5 months ago

Schrodinger announces expanded license agreement with Novartis

Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...

GuruFocus.com

5 months ago

Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...

Thomson Reuters StreetEvents

5 months ago

Q3 2024 Schrodinger Inc Earnings Call

Argus Research

5 months ago

SDGR: Raising target price to $18.00

Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details

Benzinga

5 months ago

Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details

Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates

Zacks

5 months ago

Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates

Schrödinger Reports Third Quarter 2024 Financial Results

Business Wire

5 months ago

Schrödinger Reports Third Quarter 2024 Financial Results

Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis

Business Wire

5 months ago

Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis

Schrodinger Inc (SDGR) Q3 2024 Earnings Report Preview: What to Expect

GuruFocus.com

5 months ago

Schrodinger Inc (SDGR) Q3 2024 Earnings Report Preview: What to Expect

Argus Research

5 months ago

SDGR: Lowering target price to $14.00

Schrödinger to Present at Jefferies London Healthcare Conference

Business Wire

5 months ago

Schrödinger to Present at Jefferies London Healthcare Conference

Schrödinger to Announce Third Quarter 2024 Financial Results on November 12

Business Wire

5 months ago

Schrödinger to Announce Third Quarter 2024 Financial Results on November 12

iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?

Zacks

5 months ago

iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?

Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium

Business Wire

5 months ago

Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

5 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium

Business Wire

6 months ago

Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium

Argus Research

6 months ago

SDGR: What does Argus have to say about SDGR?

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

6 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (SDGR): A Bull Case Theory

Insider Monkey

6 months ago

Schrödinger, Inc. (SDGR): A Bull Case Theory

Schrödinger, Inc. (SDGR): Among The Best Medical AI Companies

Insider Monkey

7 months ago

Schrödinger, Inc. (SDGR): Among The Best Medical AI Companies

Argus Research

7 months ago

SDGR: What does Argus have to say about SDGR?

Argus Research

7 months ago

SDGR: Raising target price to $16.00

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

7 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Business Wire

8 months ago

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Schrödinger Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

8 months ago

Schrödinger Second Quarter 2024 Earnings: Beats Expectations

Thomson Reuters StreetEvents

8 months ago

Q2 2024 Schrodinger Inc Earnings Call

Compared to Estimates, Schrodinger (SDGR) Q2 Earnings: A Look at Key Metrics

Zacks

8 months ago

Compared to Estimates, Schrodinger (SDGR) Q2 Earnings: A Look at Key Metrics

Schrodinger, Inc. (SDGR) Reports Q2 Loss, Tops Revenue Estimates

Zacks

8 months ago

Schrodinger, Inc. (SDGR) Reports Q2 Loss, Tops Revenue Estimates

Schrödinger Reports Strong Second Quarter 2024 Financial Results

Business Wire

8 months ago

Schrödinger Reports Strong Second Quarter 2024 Financial Results

Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology

Business Wire

8 months ago

Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology

Omnicell (OMCL) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

8 months ago

Omnicell (OMCL) Expected to Beat Earnings Estimates: Should You Buy?

Earnings Preview: Schrodinger, Inc. (SDGR) Q2 Earnings Expected to Decline

Zacks

8 months ago

Earnings Preview: Schrodinger, Inc. (SDGR) Q2 Earnings Expected to Decline

Argus Research

8 months ago

SDGR: Lowering target price to $18.00

We're Not Very Worried About Schrödinger's (NASDAQ:SDGR) Cash Burn Rate

Simply Wall St.

8 months ago

We're Not Very Worried About Schrödinger's (NASDAQ:SDGR) Cash Burn Rate

Schrödinger to Announce Second Quarter 2024 Financial Results on July 31

Business Wire

8 months ago

Schrödinger to Announce Second Quarter 2024 Financial Results on July 31

Argus Research

8 months ago

SDGR: Raising target price to $19.00

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

8 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Argus Research

9 months ago

SDGR: What does Argus have to say about SDGR?

Argus Research

9 months ago

SDGR: Raising target price to $16.00

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

10 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger to Present at Jefferies Global Healthcare Conference

Business Wire

10 months ago

Schrödinger to Present at Jefferies Global Healthcare Conference

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

10 months ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

What's the Difference Between Biotech Stocks and TechBio Stocks?

Motley Fool

a year ago

What's the Difference Between Biotech Stocks and TechBio Stocks?

Schrödinger, Inc. (NASDAQ:SDGR) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Schrödinger, Inc. (NASDAQ:SDGR) Q1 2024 Earnings Call Transcript

Schrödinger First Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

a year ago

Schrödinger First Quarter 2024 Earnings: Misses Expectations

GuruFocus.com

a year ago

Schrodinger Inc (SDGR) Q1 2024 Earnings Call Transcript Highlights: A Mixed Start with ...

Schrodinger Inc (SDGR) Misses Revenue Expectations in Q1 2024

GuruFocus.com

a year ago

Schrodinger Inc (SDGR) Misses Revenue Expectations in Q1 2024

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates

Zacks

a year ago

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates

Schrödinger Reports First Quarter 2024 Financial Results

Business Wire

a year ago

Schrödinger Reports First Quarter 2024 Financial Results

Argus Research

a year ago

SDGR: What does Argus have to say about SDGR?

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Institutional investors must be pleased after a 11% gain last week that adds to Schrödinger, Inc.'s (NASDAQ:SDGR) one-year returns

Simply Wall St.

a year ago

Institutional investors must be pleased after a 11% gain last week that adds to Schrödinger, Inc.'s (NASDAQ:SDGR) one-year returns

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

Business Wire

a year ago

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

13 Best Stocks to Buy and Hold According to Bill Gates’ Portfolio

Insider Monkey

a year ago

13 Best Stocks to Buy and Hold According to Bill Gates’ Portfolio

Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting

Business Wire

a year ago

Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Billionaire Bill Gates Has 35% of His Portfolio Invested in These 2 Artificial Intelligence (AI) Stocks: Are They No-Brainer Buys?

Motley Fool

a year ago

Billionaire Bill Gates Has 35% of His Portfolio Invested in These 2 Artificial Intelligence (AI) Stocks: Are They No-Brainer Buys?

The Hot List: 3 AI Stocks Worth Buying on Weakness

InvestorPlace

a year ago

The Hot List: 3 AI Stocks Worth Buying on Weakness

Schrödinger, Inc. (NASDAQ:SDGR) Analysts Just Slashed This Year's Estimates

Simply Wall St.

a year ago

Schrödinger, Inc. (NASDAQ:SDGR) Analysts Just Slashed This Year's Estimates

Thomson Reuters StreetEvents

a year ago

Q4 2023 Schrodinger Inc Earnings Call

Share on Social Networks: